Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01922921
Title Vaccine Therapy With or Without Polysaccharide-K in Treating Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Washington
Indications

Her2-receptor positive breast cancer

Therapies

HER-2/neu intracellular domain protein + Pertuzumab + Polysaccharide-K + Trastuzumab

HER-2/neu intracellular domain protein + Pertuzumab + Trastuzumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.